CYTEK BIOSCIENCES INC (CTKB)
US23285D1090 - Common Stock
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 33.80M | 22.41M | 123.40M | 18.90M | 10.70M | |||
| Cash Equivalents | 144.09M | 144.89M | 173.20M | 345.70M | 154.60M | |||
| Marketable Securities | 99.32M | 95.11M | 44.50M | N/A | N/A | |||
| Receivables | 44.75M | 56.12M | 50.90M | 29.60M | 18.10M | |||
| Inventories | 50.07M | 60.88M | 48.20M | 32.20M | 23.00M | |||
| Other Current Assets | 12.05M | 12.65M | 13.80M | 5.30M | 2.20M | |||
| Total Current Assets | 384.08M | 392.06M | 454.00M | 431.70M | 208.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 27.44M | 29.26M | 27.60M | 5.90M | 2.10M | |||
| Goodwill | 16.18M | 16.18M | 10.10M | 10.10M | 500.00K | |||
| Intangibles | 21.42M | 23.08M | 4.30M | 4.70M | 300.00K | |||
| Other Non-Current Assets | 34.60M | 33.87M | 23.40M | 10.80M | 8.50M | |||
| Total Non-Current Assets | 99.64M | 102.40M | 65.50M | 31.60M | 11.40M | |||
| TOTAL ASSETS | 483.73M | 494.46M | 519.50M | 463.30M | 220.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 2.80M | |||
| Current Portion Of LT Debt. | 1.93M | 565.00K | 600.00K | N/A | N/A | |||
| Accrued Expenses | 19.02M | 24.24M | 25.50M | 16.70M | 9.60M | |||
| Accounts Payable | 3.19M | 3.03M | 4.80M | 3.00M | 2.90M | |||
| Other Current Liabilities | 28.24M | 28.39M | 18.20M | 13.50M | 11.20M | |||
| Total Current Liabilities | 52.38M | 56.23M | 49.00M | 33.20M | 26.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.33M | 1.65M | 2.30M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 40.89M | 43.52M | 42.60M | 24.70M | 15.20M | |||
| Total Non-Current Liabilities | 42.22M | 45.17M | 45.20M | 25.10M | 15.20M | |||
| TOTAL LIABILITIES | 94.60M | 101.39M | 94.20M | 58.30M | 41.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -45.78M | -29.18M | -17.00M | -19.60M | -22.60M | |||
| Additional Paid In Capital | 434.97M | 423.39M | 442.90M | 423.60M | 6.50M | |||
| Minority Interest | N/A | 0.00 | 300.00K | 300.00K | N/A | |||
| Common Shares | 132.00K | 131.00K | 100.00K | 100.00K | 194.30M | |||
| Other Shareholders' Equity | -195.00K | -1.27M | -700.00K | 900.00K | 100.00K | |||
| Shares Outstanding | 131.51M | 130.71M | 135.40M | 133.70M | 130.80M | |||
| Tangible Book Value per Share | 2.67 | 2.71 | 3.03 | 2.92 | -0.13 | |||
| Total Shareholders' Equity | 389.12M | 393.06M | 425.30M | 405.00M | 178.30M | |||
| TOTAL LIABILITIES AND EQUITY | 483.73M | 494.46M | 519.50M | 463.30M | 220.00M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.01 | N/A | N/A | |||
| Current Ratio | 7.33 | 6.97 | 9.27 | 13.00 | 7.87 | |||
| Return On Assets (ROA) | -3.63% | -2.46% | 0.50% | N/A | 1.45% | |||
| Return On Equity (ROE) | -4.51% | -3.09% | 0.61% | N/A | 1.79% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 1.73% | 5.51% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | 8.80% | 25.95% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | 10.67% | 26.46% | |||
All data in USD , ROIC based on taxRate of 0.21